Stockscreener 앱 받기
4.81
1.19%
-0.04
전일 마감가:
$4.85
열려 있는:
$4.89
하루 거래량:
237.68K
Relative Volume:
0.19
시가총액:
$426.98M
수익:
$73.48M
순이익/손실:
$-108.30M
주가수익비율:
-2.1378
EPS:
-2.25
순현금흐름:
$-67.17M
1주 성능:
+0.26%
1개월 성능:
-13.96%
6개월 성능:
+16.60%
1년 성능:
-11.09%
1일 변동 폭
$4.73
$4.98
1주일 범위
$4.6524
$4.98
52주 변동 폭
$2.8262
$7.79
Personalis Inc Stock (PSNL) Company Profile
명칭
Personalis Inc
전화
650-752-1300
주소
6600 DUMBARTON CIRCLE, FREMONT, CA
PSNL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
4.815 | 426.54M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
479.12 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
194.98 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
631.17 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.65 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
180.81 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-15 | 개시 | Guggenheim | Buy |
| 2025-03-17 | 개시 | Craig Hallum | Buy |
| 2023-02-06 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-11-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | 다운그레이드 | Needham | Buy → Hold |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-20 | 재확인 | Needham | Buy |
| 2021-05-06 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-01-28 | 개시 | Truist | Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-12 | 재확인 | Needham | Buy |
| 2020-11-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-08-27 | 개시 | H.C. Wainwright | Buy |
| 2020-08-18 | 개시 | Needham | Buy |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | 개시 | BofA/Merrill | Neutral |
| 2019-07-15 | 개시 | Cowen | Outperform |
| 2019-07-15 | 개시 | Morgan Stanley | Overweight |
| 2019-07-15 | 개시 | Oppenheimer | Outperform |
모두보기
Personalis Inc 주식(PSNL)의 최신 뉴스
Personalis announces new data from neoadjuvant lung cancer trial - MarketScreener
Personalis reports data from lung cancer trial (PSNL:NASDAQ) - Seeking Alpha
Personalis MRD test predicts outcomes in lung cancer trial - Investing.com
Ultra-Sensitive Cancer Detection: Personalis Test Predicts Lung Cancer Outcomes 16 Months Earlier - Stock Titan
Signal strength of Personalis Inc. stock in tech scannersEarnings Overview Report & Safe Investment Capital Preservation Plans - Newser
Is Personalis Inc. reversing from oversold territoryTrade Performance Summary & Detailed Earnings Play Alerts - Newser
Is Personalis Inc. benefiting from interest rate changes2025 Market Trends & Reliable Price Action Trade Plans - khodrobank.com
How to build a dashboard for Personalis Inc. stockJuly 2025 Trade Ideas & Safe Entry Point Alerts - Newser
Is Personalis Inc. showing signs of accumulation2025 Major Catalysts & AI Powered Buy/Sell Recommendations - Newser
Is Personalis Inc. stock poised for growthTrade Analysis Summary & Short-Term Trading Alerts - Newser
Chart based exit strategy for Personalis Inc.2025 Dividend Review & Community Supported Trade Ideas - Newser
Can Personalis Inc. expand its profit marginsJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - khodrobank.com
Full technical analysis of Personalis Inc. stockQuarterly Performance Summary & Scalable Portfolio Growth Ideas - Newser
Personalis Inc. stock momentum explained2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
Using Bollinger Bands to evaluate Personalis Inc.July 2025 EndofMonth & Precise Swing Trade Entry Alerts - Newser
How hedge fund analytics apply to Personalis Inc. stock2025 Performance Recap & Free Technical Confirmation Trade Alerts - Newser
What are Personalis Inc.’s recent SEC filings showingTrade Signal Summary & AI Enhanced Trading Alerts - khodrobank.com
Personalis Inc. stock trend outlook and recovery pathJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Personalis gains as VA awards work order worth up to $13.5M - MSN
Advanced analytics toolkit walkthrough for Personalis Inc.2025 Year in Review & Risk Managed Investment Entry Signals - Newser
Is Personalis Inc. stock ready for a breakoutJuly 2025 Recap & Community Verified Trade Signals - Newser
How to escape a deep drawdown in Personalis Inc.Options Play & Consistent Profit Focused Trading Strategies - Newser
How to read the order book for Personalis Inc.Swing Trade & Free Weekly Watchlist of Top Performers - Newser
Can Personalis Inc. benefit from deglobalizationInsider Buying & Momentum Based Trading Signals - خودرو بانک
Chart based analysis of Personalis Inc. trendsStop Loss & AI Driven Price Forecasts - Newser
Can a trend reversal in Personalis Inc. lead to recoveryMarket Risk Summary & Entry Point Confirmation Alerts - Newser
Advanced analytics toolkit walkthrough for Personalis Inc2025 Geopolitical Influence & Capital Protection Trading Alerts - Newser
Personalis Inc. recovery potential after sell offJuly 2025 Big Picture & Stepwise Entry and Exit Trade Signals - Newser
Technical signs of recovery in Personalis Inc.Options Play & Long-Term Investment Growth Plans - Newser
What candlestick patterns are forming on Personalis Inc.2025 Institutional Moves & Weekly Breakout Watchlists - Newser
Tools to assess Personalis Inc.’s risk profile2025 Price Momentum & AI Enhanced Trading Signals - Newser
What makes Personalis Inc. stock price move sharplyWeekly Risk Report & AI Based Buy and Sell Signals - Newser
Personalis Inc (PSNL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Personalis Inc 주식 (PSNL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tachibana Aaron | CFO AND COO |
Jul 28 '25 |
Sale |
6.57 |
641 |
4,211 |
164,458 |
| Tachibana Aaron | CFO AND COO |
May 16 '25 |
Sale |
4.95 |
1,291 |
6,390 |
165,099 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
May 16 '25 |
Sale |
4.95 |
1,675 |
8,291 |
64,200 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
May 16 '25 |
Sale |
4.95 |
910 |
4,504 |
124,957 |
| Tachibana Aaron | CFO AND COO |
Jan 28 '25 |
Sale |
5.79 |
708 |
4,099 |
166,390 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
0.54%
0.19%
자본화:
|
볼륨(24시간):